Seelaus Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,600
Closed -$260K – 261
2022
Q1
$260K Hold
3,600
– – 0.15% 197
2021
Q4
$331K Sell
3,600
-250
-6% -$29.9K 0.18% 169
2021
Q3
$488K Hold
3,850
– – 0.29% 111
2021
Q2
$640K Sell
3,850
-1,175
-23% -$190K 0.37% 75
2021
Q1
$913K Sell
5,025
-215
-4% -$49.9K 0.59% 49
2020
Q4
$1.05M Buy
5,240
+15
+0.3% +$3.05K 0.76% 35
2020
Q3
$1.15M Buy
5,225
+100
+2% +$21.2K 0.92% 34
2020
Q2
$978K Sell
5,125
-1,300
-20% -$228K 0.89% 40
2020
Q1
$996K Buy
6,425
+750
+13% +$87.3K 1.18% 30
2019
Q4
$475K Buy
5,675
+1,250
+28% +$95.1K 0.38% 82
2019
Q3
$300K Buy
4,425
+375
+9% +$24.7K 0.26% 107
2019
Q2
$269K Buy
4,050
+225
+6% +$13.1K 0.24% 116
2019
Q1
$213K Buy
+3,825
New +$234K 0.2% 140
2018
Q4
– Sell
-2,975
Closed -$257K – 176
2018
Q3
$257K Buy
+2,975
New +$212K 0.21% 129

Other funds holding TDOC

Seelaus Asset Management's TDOC Position: Q2 2022 in Review

Seelaus Asset Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,600 shares — an estimated $260K sold.

Seelaus Asset Management first reported a position in TDOC in Q3 2018 and held it in 14 quarters. The position peaked at $1.15M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Seelaus Asset Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Seelaus Asset Management sold 3,600 Teladoc Health shares in Q2 2022, an estimated $260K.
  • Seelaus Asset Management first reported a position in Teladoc Health in Q3 2018 and held it in 14 quarters.
  • Seelaus Asset Management's Teladoc Health position peaked at $1.15M in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Seelaus Asset Management's 13F filing for Q2 2022, filed 5 Aug 2022.